citalopram and ketamine

citalopram has been researched along with ketamine in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (19.05)29.6817
2010's14 (66.67)24.3611
2020's3 (14.29)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Faller, B; Trunzer, M; Zimmerlin, A1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bjørnholm, B; Elfving, B; Knudsen, GM1
Barann, M; Bönisch, H; Lyutenska, M; Stamer, UM; Stüber, F; Urban, B1
Guo, J; Liu, WX; Qiu, LL; Sun, HL; Wang, XM; Yang, JJ; Zhang, GF; Zhou, ZQ1
Gaweł, M; Młyniec, K; Nowak, G1
Chiu, HF; Correll, CU; Fang, JX; Hu, YD; Ma, X; Sha, S; Shi, H; Tian, TF; Ungvari, GS; Wang, G; Wu, AS; Xiang, YT; Xue, Y; Zu, S1
Anderson, WH; Catlow, JT; Felder, CC; Higgs, RE; Kuo, MS; Laksmanan, A; Li, X; Martin, AE; Nikolayev, A; Schober, DA; Tolstikov, VV; Witkin, JM1
Aguilar-Valles, A; Cao, R; Comai, S; De Gregorio, D; Eslamizade, MJ; Gobbi, G; Haji, N; Lacaille, JC; Luheshi, G; Matta-Camacho, E; Mechawar, N; Nadon, R; Nuñez, N; Popic, J; Rummel, C; Sharma, V; Sonenberg, N; Tanti, A; Turecki, G; Wiebe, S1
Gruca, P; Lason, M; Litwa, E; Niemczyk, M; Papp, M; Tota-Glowczyk, K; Willner, P1
Alexander, L; Clarke, HF; Cockcroft, GJ; Fryer, TD; Gaskin, PLR; Hong, YT; Roberts, AC; Sawiak, SJ1
Bajbouj, M; Cooper, K; Daly, EJ; Drevets, WC; Hough, D; Lane, R; Lim, P; Manji, H; Mazzucco, C; Molero, P; Popova, V; Shelton, RC; Singh, JB; Thase, ME; Trivedi, M; Vieta, E1
Ameele, HVD; Blier, P; Daly, EJ; Drevets, WC; Fava, M; Fedgchin, M; Gaillard, R; Hough, D; Lane, R; Liebowitz, M; Lim, P; Manji, H; Melkote, R; Preskorn, S; Ravindran, A; Singh, JB; Trivedi, M; Vitagliano, D1
Wang, G; Wang, H; Wu, C; Yao, R; Yuan, M1
Bracke, F; Frieling, H; Leffler, A1
Fox, KR; Funsch, KM; Harris, LM; Huang, X; Ribeiro, JD1

Reviews

3 review(s) available for citalopram and ketamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Efficacy and safety of riluzole for depressive disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Psychiatry research, 2020, Volume: 284

    Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Humans; Ketamine; Male; Middle Aged; Randomized Controlled Trials as Topic; Riluzole; Treatment Outcome

2020
Efficacy of psychotropic medications on suicide and self-injury: a meta-analysis of randomized controlled trials.
    Translational psychiatry, 2022, 09-21, Volume: 12, Issue:1

    Topics: Citalopram; Humans; Ketamine; Randomized Controlled Trials as Topic; Self-Injurious Behavior; Suicidal Ideation; Suicide; Suicide, Attempted

2022

Trials

3 trial(s) available for citalopram and ketamine

ArticleYear
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Psychological medicine, 2016, Volume: 46, Issue:3

    Topics: Administration, Intravenous; Adolescent; Adult; Antidepressive Agents; China; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Ketamine; Male; Middle Aged; Outpatients; Personality Inventory; Proportional Hazards Models; Psychiatric Status Rating Scales; Self Report; Severity of Illness Index; Treatment Outcome; Young Adult

2016
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    The American journal of psychiatry, 2019, 06-01, Volume: 176, Issue:6

    Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
    The international journal of neuropsychopharmacology, 2019, 10-01, Volume: 22, Issue:10

    Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Antidepressive Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Ketamine; Male; Middle Aged; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2019

Other Studies

15 other study(ies) available for citalopram and ketamine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation.
    Journal of medicinal chemistry, 2009, Jan-22, Volume: 52, Issue:2

    Topics: Chromatography, Liquid; Drug Design; Humans; Likelihood Functions; Microsomes, Liver; Pharmacokinetics; Tandem Mass Spectrometry

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Interference of anaesthetics with radioligand binding in neuroreceptor studies.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:6

    Topics: Anesthetics; Animals; Biological Transport; Brain; Citalopram; Drug Combinations; Halothane; Isoflurane; Ketamine; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Tiletamine; Tomography, Emission-Computed; Tritium; Xylazine; Zolazepam

2003
Effects of opioids on human serotonin transporters.
    Naunyn-Schmiedeberg's archives of pharmacology, 2015, Volume: 388, Issue:1

    Topics: Alfentanil; Analgesics, Opioid; Blood Platelets; Citalopram; Fentanyl; HEK293 Cells; Humans; Hydromorphone; Ketamine; Meperidine; Morphine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tramadol

2015
Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects.
    European psychiatry : the journal of the Association of European Psychiatrists, 2015, Volume: 30, Issue:4

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Exploratory Behavior; Ketamine; Rats; Rats, Wistar; Swimming

2015
Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists.
    Behavioural brain research, 2015, Volume: 287

    Topics: Animals; Antidepressive Agents; Citalopram; Depression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Imipramine; Ketamine; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Motor Activity; Psychological Tests; Reboxetine; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Swimming

2015
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
    CNS & neurological disorders drug targets, 2017, Volume: 16, Issue:4

    Topics: Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Frontal Lobe; Ketamine; Male; Metabolome; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Quinoxalines; Receptor, Muscarinic M1; Receptors, AMPA; Scopolamine; Selective Serotonin Reuptake Inhibitors; TOR Serine-Threonine Kinases

2017
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.
    Nature communications, 2018, 06-25, Volume: 9, Issue:1

    Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzofurans; Citalopram; Depression; Depressive Disorder, Major; Eukaryotic Initiation Factor-4E; Female; Fluoxetine; Inflammation; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Serotonin and Noradrenaline Reuptake Inhibitors; Synaptic Transmission; Tumor Necrosis Factor-alpha

2018
Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
    Behavioural pharmacology, 2019, Volume: 30, Issue:2 and 3-Sp

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Ketamine; Male; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride

2019
Fractionating Blunted Reward Processing Characteristic of Anhedonia by Over-Activating Primate Subgenual Anterior Cingulate Cortex.
    Neuron, 2019, 01-16, Volume: 101, Issue:2

    Topics: Anhedonia; Animals; Blood Pressure; Callithrix; Citalopram; Conditioning, Classical; Discrimination, Psychological; Disease Models, Animal; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Food Preferences; Gyrus Cinguli; Humans; Ketamine; Locomotion; Male; Proto-Oncogene Proteins c-fos; Reward; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Sucrose

2019
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
    Pharmacology, 2022, Volume: 107, Issue:9-10

    Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels

2022